XML 23 R6.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Net income $ 59,059 $ 39,471 $ 38,386
Adjustments to reconcile net income to net cash from operating activities      
Depreciation and amortization 16,778 14,585 14,344
Bad debt provision 83,079 46,760 35,604
Deferred income taxes 19,202 (2,944) (4,820)
Share-based compensation expense 12,005 9,165 8,985
Amortization of premium on marketable securities 295 1,504 2,144
Unrealized gain on deferred compensation fund investments (7,326) (8,168) (6,645)
Changes in other long-term liabilities (384) (564) (1,154)
Net loss on disposals of property and equipment 422 654 818
Share of loss from equity method investment 2,386 532 0
Changes in operating assets and liabilities:      
Accounts and notes receivable 5,227 (61,809) (74,559)
Inventories and supplies (48) 1,731 2,685
Prepaid expenses and other assets 2,623 704 12,750
Deferred compensation funding 318 (534) (674)
Accounts payable and other accrued expenses and current liabilities (12,064) (9,741) 7,430
Deferred ERC Credits 12,277 0 0
Accrued payroll and related taxes (19,162) (3,573) 4,186
Income taxes receivable (payable) (30,637) 1,190 572
Accrued insurance claims (6,503) (7,362) (4,329)
Deferred compensation liability 7,421 9,201 7,775
Net cash from operating activities 144,968 30,802 43,498
Cash flows from investing activities:      
Proceeds from disposals of property and equipment 105 211 121
Additions to property and equipment (5,818) (6,336) (5,406)
Cash paid for acquisition (7,153) 0 0
Cash paid for investments (2,625) (2,750) 0
Purchases of marketable securities (18,717) (52,090) 0
Sales of marketable securities 23,205 67,012 1,992
Net cash from investing activities (11,003) 6,047 (3,293)
Cash flows from financing activities:      
Purchases of treasury stock (61,586) (5,018) (11,283)
Repayments of short-term borrowings 0 (25,000) 0
Payments of statutory withholding on net issuance of common stock (1,744) (1,030) (871)
Net cash from financing activities (63,330) (31,048) (12,154)
Net increase in cash, cash equivalents, and restricted cash equivalents 70,635 5,801 28,051
Cash, cash equivalents and restricted cash equivalents at beginning of the period 60,131 54,330 26,279
Cash, cash equivalents and restricted cash equivalents at end of the period 130,766 60,131 54,330
Supplementary cash flow information:      
Cash paid for interest $ 1,680 $ 6,491 $ 7,809